Crossmark

Increased level of serum asymmetric dimethylarginine in individuals with more severe cognitive impairment, as evaluated using Montreal Cognitive Assessment instead of Mini-Mental State Examination

Crossref DOI link: https://doi.org/10.1186/s40359-025-02715-y

Published Online: 2025-04-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Lei

Guan, Jia-Xin

Song, Zhi-Qiang

Gao, Qiang

Cheng, Su-Jun

Yan, Zhao-Qi

Fan, Ying
Funding

Funding for this research was provided by:

The Joint Guidance Project of Heilongjiang Provincial Natural Science Foundation (LH2020H051)

The Foundation of Harbin Science Technology Bureau (2014RFQGJ042)
License Information

Text and Data Mining valid from 2025-04-18

Version of Record valid from 2025-04-18
More Information

Article History

Received: 28 December 2023

Accepted: 8 April 2025

First Online: 18 April 2025

Declarations

:

: This study followed the Declaration of Helsinki and was approved by the Ethics Committee of Second Affiliated Hospital of Harbin Medical University. Written informed consent was obtained from all participants.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below